Retail Pharmacy, Hospital Pharmacy and Sterile Compounding HVAC Duct Guide — USP <797>, USP <800>, PIC/S PE 010, TGA GMP, ISO 14644

Why pharmacy HVAC sits between retail building and pharmaceutical GMP

An Australian pharmacy is, in HVAC engineering terms, the most varied building type our team works on. The front-of-shop at a 250 square metre Chemist Warehouse or Priceline store is conventional commercial retail — ten litres per second per person of outdoor air to AS 1668.2, 22 to 24 degrees Celsius, ducted to AS 4254 Class A in G90 galvanised steel, indistinguishable in mechanical terms from any other shopfront in the same strip mall. The back-of-house dispensary fifteen metres behind that same shopfront holds Schedule 4 prescription stock at 15 to 25 degrees Celsius with continuous temperature monitoring, a Schedule 8 controlled drug safe with access-control logging, a pharmaceutical-grade refrigerator holding cold-chain vaccines and insulin at 2 to 8 degrees Celsius with five-minute data-logger recording, and a methadone dispensing booth running an opioid pharmacotherapy program for patients on the Pharmaceutical Benefits Scheme. Walk through a connecting corridor and you are inside an ISO 7 Grade B buffer room with HEPA H14 terminal supply at 30 to 60 air changes per hour, holding plus 5 Pa to an ISO 8 Grade C ante-room, where a registered compounding pharmacist is drawing up a total parenteral nutrition admixture inside a Class II Type A2 biological safety cabinet under USP <797> aseptic protocol. Walk through a parallel airlock chain and the cascade reverses — minus 5 Pa instead of plus — into a Containment Secondary Engineering Control where a Class II Type B2 BSC is exhausting 100 percent of its cabinet airflow through bag-in bag-out HEPA H14 to a rooftop stack, while a chemotherapy pharmacist reconstitutes a 5-fluorouracil infusion for an oncology day-clinic patient.

Four buildings, four mechanical engineering disciplines, frequently inside the same address. The 2026 Australian pharmacy sector spans 5,800 community pharmacies under the Pharmacy Guild of Australia umbrella, every public and private hospital with a pharmacy department from the Royal Prince Alfred Sydney to the smallest regional health service, a growing specialist compounding sector led by National Custom Compounding in Brisbane and Slade Pharmacy in Melbourne, and a rapidly-scaling online pharmacy fulfilment sector built around Chemist Warehouse online, Pharmacy Online, Amcal Online, Instant Scripts and the digital-native cohort at Eucalyptus, Hub Health and Honeysuckle Health. The HVAC ductwork that serves these operations covers conventional retail ventilation, healthcare clean controlled environments, GMP-adjacent sterile compounding cleanrooms, USP <800> hazardous-drug containment exhaust, cold-chain and frozen storage envelopes and high-throughput warehouse fulfilment — sometimes within a single facility, more often across the project portfolios that mechanical contractors and fit-out builders quote across the Australian eastern seaboard.

This guide is the design reference SBKJ engineers in Box Hill North Victoria use when briefed by mechanical consultants, healthcare project managers, pharmacy fit-out builders, hospital capital works teams and pharmacy chain construction managers tendering ductwork for pharmacy and compounding scopes. It walks through the regulatory framework that binds pharmacy HVAC, the workflow and zone matrix at every facility type, the cascade and material selection for sterile and hazardous-drug compounding, and the SBKJ machine pattern that fabricates the duct package end-to-end. It is not a substitute for a registered mechanical engineering design, a TGA GMP licence consultation, a Pharmacy Board of Australia (AHPRA) registration audit or a qualified compounding pharmacist's technical specification.

The Australian pharmacy regulatory and standards stack

Pharmacy HVAC in Australia is governed by a layered stack of mandatory standards, harmonised international codes, professional practice standards and Australian Standards. No single document defines the complete envelope — a registered pharmacist running a sterile compounding suite navigates four to seven simultaneous standards before opening the buffer room door.

Pharmacy Board of Australia (AHPRA) and state drug and poisons regulation

Every pharmacist practising in Australia is registered with the Pharmacy Board of Australia under the Australian Health Practitioner Regulation Agency (AHPRA). The Pharmacy Board sets the registration standards, the code of conduct, and the specific guidelines on dispensing, compounding and the supply of medicines. State Acts — the Drugs, Poisons and Controlled Substances Act 1981 (Victoria), the Poisons and Therapeutic Goods Act 1966 (NSW), the Health (Drugs and Poisons) Regulation 1996 (Queensland), the Controlled Substances Act 1984 (SA), the Medicines and Poisons Act 2014 (WA), the Medicines, Poisons and Therapeutic Goods Act 2008 (ACT), the Poisons Act 1971 (Tasmania) and the Medicines, Poisons and Therapeutic Goods Act 2012 (NT) — set the scheduling framework that determines storage, dispensing and supply requirements. Schedule 2 (pharmacy-only), Schedule 3 (pharmacist-only), Schedule 4 (prescription-only), Schedule 8 (controlled drugs requiring CD safe storage) and Schedule 9 (prohibited substances by exemption only) drive the storage HVAC and access-control requirements at every pharmacy. The Pharmacy Guild of Australia is the peak body for community pharmacy operating the Quality Care Pharmacy Program (QCPP) accreditation. The Society of Hospital Pharmacists of Australia (SHPA) is the peak body for hospital pharmacy. The Pharmaceutical Society of Australia (PSA) covers the broader professional society.

USP <797> Pharmaceutical Compounding Sterile Preparations

USP <797> is the global standard for sterile compounding — published by the United States Pharmacopeia and adopted in substance by compounding pharmacies in Australia, the UK, Canada and most other jurisdictions where modern pharmacy practice operates. The 2023 revision tightened the requirements substantially: Category 1 sterile preparations (low risk, used within 12 hours, prepared in segregated compounding area), Category 2 (low and medium risk, used within 31 days when refrigerated and supported by sterility testing for longer beyond-use dates), and Category 3 (high risk, multiple-dose products with extended beyond-use dates supported by full sterility testing per USP <71>). Each Category drives the HVAC, beyond-use date validation, environmental monitoring frequency and operator competency requirements. The cleanroom envelope is the same across all three Categories: ISO 5 PEC inside ISO 7 buffer room inside ISO 8 ante-room with the cascade set out in detail later in this guide.

USP <800> Hazardous Drugs Handling in Healthcare Settings

USP <800> covers hazardous drug handling across receipt, storage, preparation, administration and disposal. The hazardous-drug list is maintained by the US National Institute for Occupational Safety and Health (NIOSH) and adopted by USP <800>: antineoplastic agents (5-fluorouracil, doxorubicin, cyclophosphamide, cisplatin, paclitaxel, vincristine, methotrexate, tamoxifen, irinotecan, etoposide, ifosfamide, daunorubicin, mitomycin, bleomycin and many others), non-antineoplastic hazardous drugs (warfarin, finasteride, several immunosuppressants, hormones), and reproductive hazards. The HVAC requirements are stringent: the C-SEC (containment Secondary Engineering Control) is held at negative 5 Pa to the ante-room, the PEC is a Class II Type B2 BSC (100 percent exhaust single-pass) or a CACI (compounding aseptic containment isolator), and all exhaust passes through bag-in bag-out HEPA H14 housing to a dedicated rooftop stack. USP <800> is the load-bearing global standard for cytotoxic, chemotherapy and hazardous-drug compounding HVAC.

PIC/S PE 010 Guide to Good Practices for the Preparation of Medicinal Products in Healthcare Establishments

PIC/S PE 010 is the Pharmaceutical Inspection Co-operation Scheme guide that covers sterile compounding in healthcare establishments — complementing PIC/S PE 009 which covers pharmaceutical manufacturing GMP. Australia adopts PIC/S in full through TGA. PE 010 is the European-derived sister standard to USP <797> and aligns closely in substance: ISO 5 Grade A PEC inside ISO 7 Grade B buffer room inside ISO 8 Grade C ante-room, with cascade and ACH requirements that map directly to Annex 1 sterile manufacturing. PE 010 covers TPN, IV admixtures, eye drops and other hospital pharmacy compounding scopes.

TGA Manufacturing Code and GMP

The Therapeutic Goods Administration regulates manufactured therapeutic goods in Australia. Pharmacy compounding sits at the boundary — specifically excluded from TGA manufacturing licence requirements when prepared in response to an individual prescription (the "extemporaneous compounding exemption" under the Therapeutic Goods Act 1989 section 18(1)). Large-scale compounding that resembles manufacturing (bulk batches, multiple-dose products distributed beyond the prescribing patient) falls under TGA licence and the full PIC/S PE 009 GMP framework. National Custom Compounding and Slade Pharmacy both operate under TGA-listed manufacturing arrangements for their bulk-compounded products. The boundary is policed at the Australian Register of Therapeutic Goods (ARTG) level — products entered on the ARTG require manufacturing under TGA licence.

ASHRAE Standard 170 and ASHRAE Applications Chapter 18

ASHRAE Standard 170 (Ventilation of Health Care Facilities) is the international healthcare HVAC reference, widely cited in Australian hospital design and adopted in part through state health-department design guidelines. Standard 170 sets the air change rates, temperature, humidity, pressure relationship and filtration requirements for every space type in a hospital including the inpatient pharmacy, sterile compounding room, hazardous-drug compounding room and pharmacy storage. ASHRAE Handbook Applications Chapter 18 (Clean Spaces) is the engineering reference for cleanroom HVAC design covering ACH calculations, supply diffuser selection, return strategy, filter loading allowance and room recovery time. Both are cited as supplementary engineering references where AS 1668.2 is silent on cleanroom and healthcare requirements.

ISO 14644 and ISO 14698

ISO 14644 is the international cleanroom classification standard. ISO 14644-1 sets the particle count limits for each ISO class. ISO 14644-2 covers monitoring. ISO 14644-3 covers test methods. The mapping between USP <797> and ISO classes is direct: ISO 5 (the PEC critical zone), ISO 7 (the buffer room SEC), ISO 8 (the ante-room transition). ISO 14698 covers biocontamination control with environmental monitoring through settle plates, surface contact plates and active air sampling — the routine microbiological monitoring that every compounding suite performs as part of its Contamination Control Strategy.

AS 1668.2, AS 4254, AS 1530.4 and AS 1851

The Australian Standards stack that applies to every building. AS 1668.2 sets the mechanical ventilation floor — 10 L/s per person outdoor air, exhaust rates per space type, the local exhaust requirements that cover the methadone dispensing booth and certain compounding ventilation. AS 4254 sets ductwork construction and leakage classification — most pharmacy work is Class A or B with Class C reserved for the hazardous-drug BSC exhaust. AS 1530.4 covers fire-rated construction including fire and smoke dampers. AS 1851 covers the maintenance regime. AS 1668.1 covers fire and smoke control for the broader building. The Australian pharmacy fit-out sits within the host building's fire compartmentation under these standards.

AS/NZS 4187 reprocessing and AS 4032 medical gas

AS/NZS 4187 covers reprocessing of reusable medical devices including the sterilisation of compounding equipment between batches and the cleaning of the BSC interior between uses. AS 4032 covers medical gas reticulation where the compounding suite uses nitrogen, carbon dioxide or argon for inert-atmosphere compounding of oxygen-sensitive preparations. Both intersect HVAC design at the compounding interface.

AS 1940, AS/NZS 60079 and AS/NZS 2243.3

AS 1940 covers flammable and combustible liquids storage — relevant where compounding handles flammable cytotoxic vehicles (ethanol-based, DMSO-based, propylene glycol-based) at threshold quantities. AS/NZS 60079 covers electrical equipment in explosive atmospheres — rare in pharmacy but applicable to certain large-scale extemporaneous compounding operations and to sterilant atmospheres during ethylene oxide or hydrogen peroxide cycles. AS/NZS 2243.3 covers microbiological safety and biosafety levels — BSL-2 is the standard for compounding pharmacy microbiology QC work.

Safe Work Australia workplace exposure standards (WES)

Safe Work Australia WES values cover the airborne chemical concentrations in pharmacy compounding operations. The relevant values: carbon dioxide 5,000 ppm 8-hour TWA (general ventilation indicator); formaldehyde 1 ppm STEL (rare in pharmacy but applicable to certain fixative work); glutaraldehyde 0.05 ppm STEL (high-level disinfectant where used); peracetic acid 0.4 ppm STEL (Sterrad sterilisation cycle exhaust); ethylene oxide 1 ppm STEL (rare); ozone 0.1 ppm 8-hour TWA (UV sterilisation systems); hydrogen peroxide 1 ppm 8-hour TWA (VHP decontamination of CACI and BSC). Cytotoxic drugs have no formal WES because they are antineoplastic at any measurable concentration; the engineering control is single-pass exhaust through HEPA H13 or H14 with BIBO housing rather than a measurable workplace exposure limit. The HVAC design ensures that ACH and pressure cascade keep all airborne exposures well below the WES at routine use, with vapour and gas monitors at breathing height feeding BMS alarms at 50 percent and 100 percent of the WES.

The USP <797> sterile compounding cascade — ISO 5, ISO 7, ISO 8

Every sterile compounding suite in Australia starts from the same cascade. The cleanroom envelope reinforces the airflow direction from cleanest to less clean, the operator gowning is sized to the grade, and the environmental monitoring program tracks both at the documented periodicity. The cascade is the strongest engineering control and the specification most likely to be misdesigned at concept or to drift in operation.

ISO 5 Grade A — the Primary Engineering Control (PEC). The product contact zone during compounding. Enclosed inside a Class II Type A2 BSC (non-hazardous USP <797> work), a Laminar Airflow Workbench LAFW (also non-hazardous USP <797>), a Class II Type B2 BSC (USP <800> hazardous-drug), a Compounding Aseptic Isolator CAI (USP <797> non-hazardous) or a Compounding Aseptic Containment Isolator CACI (USP <800> hazardous-drug). Inside the enclosure: HEPA H14 unidirectional supply at 0.36 to 0.54 m/s at the working position, recirculated through HEPA return (A2 BSC and CAI) or exhausted single-pass to outdoor (B2 BSC and CACI). The PEC is the controlling zone for ISO 14644-1 Class 5 in-operation — the most demanding particle count requirement in the entire suite.

ISO 7 Grade B — the Secondary Engineering Control (SEC) buffer room. The cleanroom envelope around the PEC. Held at plus 5 Pa minimum to the ante-room (non-hazardous USP <797>) or minus 5 Pa to the ante-room (hazardous USP <800>, where the suite is renamed the C-SEC). 30 to 60 ACH minimum HEPA H14 terminal supply through non-aspirating ceiling diffusers. Type 304L stainless steel supply and return ductwork minimum throughout (Type 316L on USP <800> hazardous-drug return paths and Class II Type B2 BSC exhaust). Acoustic NC-50 maximum. Temperature 18 to 22 degrees Celsius, RH 30 to 60 percent. Operator gown is a clean room suit with head cover, mask, sterile gloves and overshoes.

ISO 8 Grade C — the ante-room transition. The gowning, hand-washing and material-staging space between the corridor and the buffer room. Held at plus 5 Pa minimum to the corridor. 20 to 30 ACH with HEPA H13 or H14 supply. Type 304L stainless steel supply and return ductwork minimum. Sticky mat at the corridor side and at the buffer-room side. Interlocked doors with the corridor door and the buffer-room door never both open simultaneously. Hand-wash basin with foot-pedal or sensor tap. Temperature 18 to 22 degrees Celsius. The ante-room is where the operator transitions from street-clothes through outer-garment gowning into clean room suit, hand hygiene and sterile glove donning before entering the buffer room.

Unclassified corridor. Ambient pressure. Conventional ducted ventilation to AS 1668.2 minimum. G90 galvanised ductwork acceptable. The unclassified envelope is the access corridor outside the ante-room. The pressure gradient corridor to ante-room to buffer room is positive 5 Pa minimum at each step, total 10 Pa minimum across the cascade.

The airlock chain at every cascade transition

Every transition from corridor to ante-room to buffer room is bridged by an airlock chain — interlocked doors at each end preventing simultaneous open-door connection between grades. The airlock chain reinforces the cascade during personnel and material flow and acts as a buffer for the inevitable transient pressure excursions when doors open. Personnel and material airlocks are typically separate where the suite volume allows; combined airlocks are used at smaller hospital pharmacy compounding suites where space is tight. Pass-through hatches at material airlocks with dwell timers (typically 30 to 60 seconds) enforce minimum interlock duration regardless of operator behaviour. HEPA H14 supply at the airlock achieves room recovery to classification within the dwell period.

Continuous BMS monitoring and audit trail

Every cascade boundary is monitored by a permanent differential pressure transducer logged on a BMS at 1-minute resolution minimum. Warning alarm at 50 percent of design differential, critical alarm at 25 percent or inversion. Door-side green and red LED indicators let the compounding pharmacist verify cascade direction without consulting the BMS screen. The BMS retains data for the life of the compounded preparation plus 5 years minimum per TGA GMP and PIC/S PE 010 where the facility operates under those frameworks. Audit-trail capability is mandatory — every change to a monitored parameter logged with named user, timestamp and reason.

The USP <800> reverse cascade — the hazardous-drug containment design

USP <800> reverses the cascade direction inside the compounding suite to contain hazardous-drug aerosol. The principle is straightforward: hazardous-drug particulate must never escape the C-SEC into the broader pharmacy, the hospital or the building HVAC system. The reversal is implemented as a localised negative-pressure containment inside an otherwise-positive cascade structure.

The cascade direction

Corridor at ambient pressure. Ante-room at plus 5 Pa minimum to corridor — preventing corridor air entering the ante-room. C-SEC (Containment Secondary Engineering Control, the hazardous-drug buffer room) at minus 5 Pa minimum to the ante-room — pulling ante-room air into the C-SEC, containing hazardous-drug aerosol inside the C-SEC. PEC (Class II Type B2 BSC or CACI) at additional negative pressure to the C-SEC — pulling C-SEC air into the cabinet, containing hazardous-drug aerosol inside the cabinet. The result is a one-way airflow path corridor into ante-room into C-SEC into PEC, with the PEC exhausting 100 percent of its airflow single-pass to outdoor through bag-in bag-out HEPA H14.

The Class II Type B2 BSC as the primary engineering control

The Class II Type B2 BSC is the load-bearing engineering item in the USP <800> package. Compared with the more common Class II Type A2 BSC (which recirculates 70 percent of cabinet airflow and exhausts 30 percent), the Type B2 BSC exhausts 100 percent single-pass to outdoor through HEPA H14 with no recirculation back to the room or to the cabinet itself. The cabinet supply is 100 percent fresh air drawn from the room through HEPA H14 prefilter. Inside the cabinet: HEPA H14 downflow at 0.36 to 0.54 m/s at the work surface, side-wall return through the work surface grilles, exhaust through the rear-mounted HEPA H14 to the dedicated exhaust duct. The cabinet is commissioned per NSF/ANSI 49 (Biosafety Cabinetry — Class II) by a certified third-party technician, with downflow velocity, exhaust velocity, HEPA integrity and smoke-pattern containment verified at handover and annually thereafter.

The bag-in bag-out (BIBO) HEPA housing

The Class II Type B2 BSC exhaust connects to a bag-in bag-out HEPA filter housing immediately upstream of the discharge fan. The BIBO is a Type 316L stainless steel cabinet with a HEPA H14 filter element changed-out by feeding the spent filter into a sealed plastic bag and feeding the new filter in through the same bag-in port without opening the housing to atmosphere. The housing has bubble-tight isolation dampers upstream and downstream so the filter chamber can be isolated and decontaminated before bag-in bag-out change-out. The housing internals are fully welded with no joint integrity less than the duct itself. Annual integrity test per IEST-RP-CC034 with PAO aerosol challenge upstream and photometer scan downstream — acceptance no penetration above 0.01 percent for H14. The change-out is a designated hazardous-drug exposure event managed under the facility's hazardous-drug safety plan with PPE for the change-out operator at the same standard as compounding-pharmacist PPE.

Activated-carbon adsorber for volatile vehicle vapour

Several cytotoxic vehicles contain volatile solvents — ethanol, DMSO (dimethyl sulfoxide), propylene glycol, polysorbate — that pass through HEPA filtration unchanged. An activated-carbon adsorber upstream of the BIBO HEPA captures the residual vapour from chemotherapy vehicle handling. The carbon bed is sized for the volatile inventory and the cabinet airflow rate, with breakthrough monitoring on cabinet outflow and a documented replacement schedule typically at six or twelve month intervals depending on usage. The carbon adsorber is mandatory for facilities compounding paclitaxel, doxorubicin, etoposide and other vehicles with significant volatile component.

The discharge stack

Class II Type B2 BSC exhaust discharges to a dedicated rooftop stack: 3 metres minimum above roof, 8 metres minimum horizontal from any outdoor air intake or operable window, 12 m/s minimum discharge velocity. The discharge fan is downstream of the BIBO HEPA so the duct between fan and stack operates at slight negative pressure to outdoor — any leak draws ambient air inward rather than allowing cytotoxic aerosol outward. The discharge fan is on emergency power with manual-restart capability through the building backup generator. Loss of discharge for more than 60 seconds is a USP <800> non-conformance event documented in the compounding suite's deviation log.

The Compounding Aseptic Containment Isolator (CACI) alternative

The Class II Type B2 BSC is the most common PEC for USP <800> in 2026 but the Compounding Aseptic Containment Isolator (CACI) is an alternative used at sites with very high cytotoxic throughput (Slade Pharmacy Melbourne, the larger hospital chemotherapy compounding services). The CACI is a closed isolator with gauntlet ports, HEPA H14 unidirectional supply, single-pass exhaust through HEPA H14 to outdoor, and pressure inside the isolator at negative 25 Pa to the surrounding C-SEC. The CACI is decontaminated between batches with vaporised hydrogen peroxide (VHP) or sporicidal surface chemistry. The CACI offers better operator protection than a B2 BSC because the operator is fully isolated from the cabinet interior by the gauntlet barrier; the trade-off is reduced visibility and the operational complexity of the VHP cycle.

The TPN total parenteral nutrition compounding suite

Total Parenteral Nutrition (TPN) compounding is the largest single category of USP <797> sterile compounding by volume across Australian hospital pharmacies. A TPN bag is a complete intravenous nutrition formula for a patient who cannot take oral nutrition — ICU patients, post-surgical patients, neonates, oncology patients on chemotherapy, patients with short-bowel syndrome or other malabsorption conditions. Each bag is custom-compounded for a specific patient with amino acids, dextrose, lipids, electrolytes (sodium, potassium, calcium, magnesium, phosphate), water-soluble and fat-soluble vitamins, and trace elements (zinc, copper, manganese, chromium, selenium). The compounding pharmacist calculates the prescription against the patient's metabolic state, draws up each component aseptically inside the PEC, and assembles the final bag in a sterile mixing port system.

Workflow and zone matrix

The TPN compounding suite is a USP <797> Category 2 sterile compounding operation (beyond-use date up to 24 hours at room temperature or 9 days refrigerated, supported by USP <797> standard environmental monitoring). The PEC is a Class II Type A2 BSC or LAFW providing ISO 5 Grade A unidirectional airflow at the working position. The PEC sits inside an ISO 7 Grade B buffer room (the SEC) at plus 5 Pa minimum to an ISO 8 Grade C ante-room. Ante-room at plus 5 Pa to corridor. Buffer room 30 to 60 ACH HEPA H14 terminal supply; ante-room 20 to 30 ACH HEPA H13 or H14. Temperature 18 to 22 degrees Celsius, RH 30 to 60 percent. Ductwork Type 304L stainless steel minimum throughout the SEC and ante-room. Continuous BMS monitoring per cascade boundary.

Australian operators

The major Australian TPN compounding operators are Slade Pharmacy in Melbourne (the largest outsourced hospital TPN, IV admixture, ophthalmic and cytotoxic compounder, serving multiple Victorian and interstate hospital networks under contract), Brisbane-based National Custom Compounding (NCC), Brisbane Custom Compounding, and the in-house TPN compounding services at Westmead Hospital, Royal Melbourne Hospital, Alfred Hospital, Monash Health, Royal Brisbane and Womens Hospital, Princess Alexandra Hospital, Royal Adelaide Hospital, Fiona Stanley Hospital, Canberra Hospital and most other tertiary and quaternary public hospitals. Several private hospital networks (Ramsay Health Care at flagship sites, Healthscope at the larger campuses, Calvary, Mater, St John of God, Cabrini and Epworth) also operate in-house TPN compounding for inpatient and oncology day-clinic populations.

HVAC design considerations specific to TPN

TPN compounding has two design considerations that distinguish it from generic USP <797> sterile compounding. First, the lipid component (typically a 20 percent intralipid emulsion of soybean oil) is shear-sensitive and temperature-sensitive — the buffer room temperature is held tighter than the generic 18 to 22 degrees Celsius envelope, typically 19 to 21 degrees Celsius with continuous BMS logging at 1-minute resolution. Second, TPN compounding has high throughput (a tertiary hospital pharmacy may compound 30 to 80 TPN bags per shift) so the buffer room is sized for sustained operator activity rather than the lower-volume occasional-use pattern of some compounding scopes. ACH is at the upper end of the USP <797> envelope (50 to 60 ACH) to maintain ISO 7 in operation under sustained activity.

The hazardous-drug cytotoxic and chemotherapy compounding suite

Chemotherapy and cytotoxic compounding is the highest-risk routine activity in hospital and oncology day-clinic pharmacy practice. The compounding pharmacist handles antineoplastic agents at concentrations that are toxic to dividing cells at any measurable exposure — meaning that a routine workplace exposure limit cannot be set on the same basis as a solvent or a sterilant. The engineering control is total containment: single-pass exhaust through HEPA H13 or H14 with BIBO housing, reverse-cascade C-SEC with negative pressure to the ante-room, Class II Type B2 BSC or CACI as the PEC, and the operator in full chemotherapy PPE.

The cytotoxic drug list

The antineoplastic agents handled in Australian hospital and oncology day-clinic pharmacies in 2026 include the classical cytotoxics (5-fluorouracil, doxorubicin, cyclophosphamide, cisplatin, paclitaxel, vincristine, methotrexate, tamoxifen, irinotecan, etoposide, ifosfamide, daunorubicin, mitomycin, bleomycin), the platinum analogues (carboplatin, oxaliplatin), the anthracyclines (idarubicin, epirubicin), the taxanes (docetaxel beyond paclitaxel), the alkylating agents beyond cyclophosphamide (ifosfamide, melphalan, busulfan), the antimetabolites beyond methotrexate (gemcitabine, capecitabine, cytarabine), the topoisomerase inhibitors beyond etoposide and irinotecan (topotecan), and the targeted therapies including monoclonal antibodies (rituximab, trastuzumab, bevacizumab, cetuximab, pembrolizumab, nivolumab) and small-molecule targeted agents (imatinib, sunitinib, sorafenib, erlotinib, gefitinib, dasatinib, nilotinib). The monoclonal antibodies are reconstituted in the same USP <800> envelope as the classical cytotoxics — the hazardous-drug list under NIOSH and USP <800> includes the monoclonal antibodies and most targeted therapies, not only the classical cytotoxics.

The compounding workflow

A typical chemotherapy compounding session: the prescription is dispensed from the oncology day-clinic or the inpatient oncology ward to the pharmacy. The pharmacist verifies the prescription against the patient's body surface area, the cycle protocol and the dose-modification rules. The vial of cytotoxic drug is taken from the dedicated cytotoxic refrigerator or pharmacy storage. The compounding pharmacist in full PPE (chemotherapy gown, double nitrile gloves, full-face shield or chemotherapy goggles, head cover, shoe covers) enters the ante-room, gowns and gloves up, washes hands at the foot-pedal basin, and enters the C-SEC. Inside the Class II Type B2 BSC: the vial is reconstituted (if a powder) with the appropriate diluent, drawn up into a syringe through a closed-system transfer device (CSTD — Tevadaptor, Equashield, ChemoClave, ChemoLock), and injected into the patient's infusion bag (saline, dextrose, Hartmann's solution or other vehicle as prescribed). The infusion bag is labelled, the syringe is disposed of in the cytotoxic sharps container, and the compounded preparation is bagged and labelled for transport to the day-clinic or ward.

HVAC design at the cabinet interface

The Class II Type B2 BSC sits inside the C-SEC with the cabinet exhaust ducted through the room ceiling to the rooftop discharge stack. The cabinet draws make-up air from the room through HEPA H14 supply diffusers immediately adjacent to the cabinet face. The room HVAC must compensate the cabinet exhaust make-up at peak cabinet airflow — if the cabinet exhausts 500 L/s, the room supply must exceed the cabinet exhaust by the room cascade differential (typically 50 to 100 L/s additional for the minus 5 Pa to ante-room differential). The cabinet position relative to the room supply diffusers matters: too close and the cabinet face velocity disrupts the diffuser pattern; too far and the cabinet draws asymmetric make-up that compromises the downflow uniformity. The standard design pattern places the cabinet 1.5 to 2 metres from the supply diffuser face with the cabinet face perpendicular to the diffuser airflow.

Closed-system transfer devices (CSTDs)

USP <800> requires closed-system transfer devices (CSTDs) for the handling of every hazardous drug from reconstitution through injection into the final preparation. A CSTD is a mechanical device that mates with the drug vial and the syringe in a sealed connection that prevents aerosol escape during transfer. The Tevadaptor, Equashield, ChemoClave, ChemoLock and BD PhaSeal are the principal CSTDs in Australian use. The CSTD reduces the aerosol burden inside the cabinet, but does not replace the BSC or the BIBO HEPA exhaust — CSTD is the operator's primary protection at the device level, the BSC is the operator's primary protection at the cabinet level, and the BIBO HEPA exhaust is the building's primary protection at the duct level. Defence in depth.

Spill response and decontamination

A cytotoxic spill inside the BSC or in the C-SEC is a hazardous-drug exposure event with documented response protocol. The spill kit includes absorbent pads, double-glove and gown PPE, chemotherapy disposal bags, sodium hypochlorite solution for surface decontamination and an incident report form. The HVAC continues running at full ACH through the spill response to maintain the cascade and to flush the room atmosphere. The BSC interior is decontaminated with sodium hypochlorite followed by neutralisation with sodium thiosulfate. The cabinet is then surface-cleaned and re-validated before the next batch. Major spills (vial breakage, infusion-bag failure) may trigger a full C-SEC decontamination with VHP cycle if the cabinet engineering control was breached.

The hospital pharmacy dispensing operation

Hospital inpatient pharmacy is the operational heart of medication supply in every Australian public and private hospital. The pharmacy receives ward and clinic prescriptions, dispenses with computerised systems, packs inpatient medication carts, supplies the ward automated dispensing cabinets (Omnicell, BD Pyxis, CareFusion), reconstitutes IV medications including antibiotics at ward-call request, and provides the clinical pharmacist services on inpatient wards. The HVAC envelope is clean controlled rather than sterile cleanroom — the dispensing function operates with HEPA H13 filtered supply at conventional pressure, with the sterile compounding suite (TPN, IV admixture, cytotoxic) as a separate cleanroom envelope inside or adjacent to the broader pharmacy footprint.

Workflow and zone matrix

The hospital pharmacy comprises: a prescription receipt and computerised dispensing area; an inpatient cart-filling room; a clean-controlled outpatient and discharge dispensing counter; the central S8 controlled drug safe; the cold-chain pharmaceutical refrigerator and walk-in cold room (50 to 500 cubic metres at the larger tertiary hospitals); the sterile compounding suite (TPN, IV admixture); the hazardous-drug compounding suite (cytotoxic, chemotherapy); the IV antibiotic reconstitution station (sometimes adjacent to ICU or the emergency department for time-critical antibiotic preparation); the pharmacy office and clinical pharmacist work area; and the bulk drug store with PBS-listed stock holdings. The HVAC envelope across these zones is mostly clean controlled at AS 1668.2 plus ASHRAE Standard 170 healthcare ventilation — the cleanroom envelopes are separate engineering scopes inside the broader pharmacy.

HVAC envelope for dispensing

The dispensing area runs at temperature 21 to 24 degrees Celsius, RH 30 to 60 percent, HEPA H13 filtered supply for dust control, slight positive pressure to the corridor (typically plus 5 Pa) for cleanliness and to prevent corridor air entering the dispensary. Ductwork is Type 304 stainless or galvanised G90 acceptable. The pharmacy sits within the hospital fire compartment with smoke and fire dampers per AS 1668.1 and AS 1530.4. The cart-filling room is the same envelope with a slightly tighter clean-controlled standard (HEPA H13 supply and minimal foot-traffic during cart-filling). The dispensing counter for outpatient and discharge prescriptions is conventional retail-pharmacy HVAC standard.

The ward automated dispensing cabinet (ADC) interface

The hospital pharmacy supplies the ward ADC units (Omnicell, BD Pyxis, CareFusion) with refilled medication. The ADC sits at the ward nurse-station and dispenses prescribed medication on patient-specific override at the ward bedside. The HVAC for the ADC at the ward is conventional ward HVAC under ASHRAE Standard 170 ward standards — not a pharmacy responsibility. The pharmacy-to-ADC supply chain is the hospital pharmacy's central cart and crash-cart drug filling, performed in the cart-filling room at the pharmacy. The pharmacist or pharmacy technician fills the cart, locks it, and the ward staff retrieve the refilled drawers via secured cart transfer through the hospital corridor and lift system.

S8 controlled drug storage and the CD safe

The hospital pharmacy operates a central S8 controlled drug safe holding the inpatient and outpatient S8 stock. The safe is a steel cabinet with electronic combination lock and access-control logging (named-user PIN, biometric or smart-card access, log retained per state drug and poisons regulation requirements). Temperature inside the safe is monitored continuously at 15 to 25 degrees Celsius. The safe is sited inside the pharmacy at a position visible to the dispensing pharmacist with double-staff access verification for routine S8 dispensing per Pharmacy Board of Australia guidance. The HVAC envelope around the safe is the same as the broader pharmacy — conventional clean controlled with no special pressure cascade requirement.

Methadone and pharmacotherapy dispensing

Hospital pharmacy methadone dispensing for opioid pharmacotherapy program patients operates from a dedicated methadone-dispensing window or counter with the patient receiving the dose under direct pharmacist observation. The dispensing window is sited at a position separate from the routine outpatient dispensing counter for patient confidentiality and program protocol. The HVAC envelope is the same as the broader pharmacy. Where the program serves a high patient volume (some inner-city public hospitals and dedicated drug-and-alcohol services), the methadone dispensing operates from a separate room within the pharmacy with its own ventilation and direct-supervision security.

The retail community pharmacy — Chemist Warehouse, Priceline and the broader sector

Australian retail community pharmacy is dominated by a handful of chains supplying through three primary wholesale routes: Sigma Healthcare (ASX:SIG, supplying Chemist Warehouse, Amcal, Guardian and the Sigma-branded stores), Wesfarmers (owner of Priceline and API/Symbion), and Sympro for the independent pharmacy network. The market is highly concentrated — Chemist Warehouse alone operates over 500 stores making it the biggest by store count, Priceline (Wesfarmers) operates approximately 470, Sigma's Amcal and Guardian brands cover several hundred more, and the independent sector under the Pharmacy Guild of Australia umbrella accounts for the balance of approximately 5,800 community pharmacies nationally.

The retail HVAC envelope

Retail community pharmacy HVAC is conventional commercial retail across the front-of-shop, with tighter controls on the back-of-house dispensary and the cold-chain refrigerator. AS 1668.2 minimum 10 L/s per person outdoor air across the customer area. Temperature 22 to 24 degrees Celsius for customer comfort. RH 40 to 60 percent for general comfort. Ducted VAV or split-system HVAC depending on the store format. Galvanised G90 ductwork to AS 4254 Class A throughout. The store sits within the host building's fire compartmentation — usually a shopping centre, strip mall or stand-alone retail building — with smoke and fire dampers per AS 1668.1 and AS 1530.4.

The dispensing counter and back-of-house dispensary

The dispensing counter and back-of-house dispensary operates at the same HVAC envelope as the front-of-shop but with continuous temperature monitoring at the medication storage shelves. Schedule 2 (pharmacy-only over-the-counter), Schedule 3 (pharmacist-only over-the-counter) and Schedule 4 (prescription-only) medications are stored at 15 to 25 degrees Celsius per the Australian Register of Therapeutic Goods (ARTG) labelling requirements. The dispensing pharmacist position is air-conditioned to the same envelope; the dispensary is sized for the pharmacist plus pharmacy assistants and the dispensing equipment (the dispensing computer running the FRED, Minfos, Z dispense or Lots software, the prescription printer, the medication picking robot at the larger stores).

The S8 controlled drug safe

The S8 controlled drug safe in a retail community pharmacy is a steel safe with electronic combination lock, sited at a position not visible to the public, with continuous temperature monitoring at 15 to 25 degrees Celsius and access-control logging per the state drug and poisons regulation. Methadone, oxycodone, fentanyl, morphine and the broader S8 stock holding sits in the safe. The pharmacist is the only authorised access — pharmacy assistants do not have S8 access at any community pharmacy. Methadone dispensing for pharmacotherapy program patients operates under the same protocol as hospital pharmacy — dosed under direct pharmacist observation at a dedicated counter or window with patient confidentiality.

Cold-chain vaccine, insulin and biologic storage

Every community pharmacy in 2026 holds cold-chain stock — influenza vaccines (seasonal), COVID-19 mRNA vaccines (where the pharmacy participates in the vaccination program), other listed vaccines on the National Immunisation Program (MMR, hepatitis B, varicella, pneumococcal, meningococcal, HPV), insulin (Humulin, NovoRapid, Lantus, Levemir, Trulicity, Ozempic, Mounjaro), monoclonal antibody injectables that the pharmacy stocks, and biologics. Storage is in pharmaceutical-grade refrigerators (Vacc-Safe, Bromic Pharma, Pharmac, Thermoline) at 2 to 8 degrees Celsius with continuous temperature monitoring and data-logger recording at 5-minute resolution per the National Vaccine Storage Guidelines "Strive for 5" protocol. Backup power and out-of-hours alarm are mandatory — loss of cold chain for more than 60 minutes triggers a Vaccine Vial Monitor (VVM) check or stock destruction per the Australian Immunisation Handbook protocol.

Vaccination consultation room

The pharmacist-administered vaccination service has expanded substantially since 2016 and now covers influenza, COVID-19, MMR, dTpa, HPV, hepatitis A and B, varicella, herpes zoster (Shingrix) and meningococcal at most accredited community pharmacies under the pharmacist-administered vaccination program operated through each state's drug and poisons regulation. The vaccination service requires a dedicated consultation room with door, hand-wash basin, vaccine-disposal sharps container and adequate ventilation. HVAC: AS 1668.2 plus the local exhaust over the vaccine-administration station, conventional dispenser to AS 4254 Class A. The room is also used for medication consultations, MedsCheck reviews under the PBS sixth and seventh community pharmacy agreement, and (where the pharmacist is accredited) for clinical interventions such as continuous glucose monitor (CGM) device fitting.

The Pharmacy Guild and Quality Care Pharmacy Program (QCPP)

The Pharmacy Guild of Australia operates the Quality Care Pharmacy Program (QCPP) accreditation that covers most accredited community pharmacies. QCPP requirements touch HVAC at the temperature monitoring, cold-chain compliance, S8 safe storage, vaccine storage and the consultation room ventilation level. The accreditation is renewed at documented periodicity with on-site audit. QCPP is not legislated but is a de facto requirement for participation in the seventh Community Pharmacy Agreement (CPA7) and access to PBS dispensing under the standard fee structure. The HVAC design at any new community pharmacy fit-out is sized to meet QCPP from day one.

The compounding pharmacy — National Custom Compounding, Slade and the specialist sector

Specialist compounding pharmacy in Australia operates at the boundary between community pharmacy and pharmaceutical manufacturing. The major operators are National Custom Compounding (NCC) in Brisbane (the largest by volume and revenue), Slade Pharmacy in Melbourne (the dominant outsourced hospital TPN, IV, ophthalmic and cytotoxic compounder), Brisbane Custom Compounding, Custom Compounding Pharmacy in Sydney, Optimum Pharmacy Plus, Wholistic Healthcare in Sydney, and a longer tail of smaller specialist compounders concentrated in the major capital cities. IDT Australia at Boronia VIC and Catalent Australia at Braeside VIC operate at the pharmaceutical CMO (contract manufacturing organisation) scale, including some compounding-adjacent services for specialty medications and clinical-trial supply — technically at the manufacturing licence end of the spectrum rather than the compounding end.

The compounding scope

The specialist compounding sector serves three primary markets. First, individual-patient extemporaneous compounding under PIC/S PE 010 Annex 1 — creams, ointments, oral capsules, troches, lollipops, paediatric flavour-adjusted suspensions, hormone-replacement-therapy custom formulations, dermatology custom preparations, veterinary medication custom formulations — all dispensed against an individual prescription and exempt from TGA manufacturing licence under the section 18(1) extemporaneous compounding exemption. Second, sterile compounding under USP <797> including hospital-outsourced TPN, IV admixture and cytotoxic compounding — the dominant Slade Pharmacy scope. Third, bulk compounding that approaches manufacturing under TGA licence — some hormone-replacement-therapy preparations, dermatology specials and veterinary formulations sold beyond a single patient prescription.

HVAC envelope for non-sterile compounding

The non-sterile extemporaneous compounding suite is operated under PIC/S PE 010 Annex 1 with clean controlled HVAC: HEPA H13 filtered supply for the powder-handling area to prevent cross-contamination between formulations, temperature 18 to 24 degrees Celsius, RH 30 to 60 percent, conventional pressure (slight positive to corridor), Type 304 stainless or galvanised G90 ductwork acceptable. The compounding area is segregated by formulation type — hormone preparations separated from antibiotic preparations separated from veterinary preparations — with dedicated equipment per category to prevent cross-contamination. The HVAC is not cleanroom-grade but is tighter than conventional dispensary, sized to support the powder-handling and dust-control requirement.

HVAC envelope for sterile compounding

The sterile compounding suite at a specialist compounder operates at the same USP <797> cascade as a hospital TPN compounding suite: ISO 5 PEC (Class II Type A2 BSC or LAFW) inside ISO 7 Grade B buffer room inside ISO 8 Grade C ante-room. Cascade plus 5 Pa per step minimum. 30 to 60 ACH in buffer room with HEPA H14 supply, 20 to 30 ACH in ante-room. Ductwork Type 304L stainless steel minimum. The major Slade Pharmacy installation in Melbourne operates multiple sterile compounding suites in parallel to support the contracted hospital TPN, IV admixture, ophthalmic and cytotoxic volume.

HVAC envelope for hazardous-drug compounding

The hazardous-drug compounding suite at a specialist compounder operates at USP <800> cascade: reverse cascade with C-SEC negative to ante-room, Class II Type B2 BSC or CACI as the PEC, BIBO HEPA H14 exhaust to dedicated rooftop stack. The major Slade Pharmacy operation runs multiple Class II Type B2 BSC stations in parallel for chemotherapy compounding across multiple Australian hospital contracts; the design pattern is identical to a hospital chemotherapy compounding suite but scaled to the higher throughput.

The online pharmacy fulfilment centre

Online pharmacy fulfilment is the fastest-growing segment of Australian pharmacy retail in the mid-2020s. The market leaders are Chemist Warehouse online (the biggest by revenue and stock-keeping unit count, fulfilling through purpose-built warehouse facilities), Pharmacy Online (independent online operator), HealthSAVE Pharmacy (loyalty-based online prescription), Amcal Online (Sigma group), Instant Scripts (Wesfarmers, combining telehealth prescribing with ePharmacy fulfilment), Hub Health (digital telehealth and pharmacy fulfilment), Honeysuckle Health (digital-native pharmacy), and Eucalyptus (operating the Mosh, Pilot and Compound brands — telehealth and compounded medication delivered direct to consumer).

The fulfilment centre footprint

An online pharmacy fulfilment centre operates at warehouse scale — 5,000 to 30,000 square metres for the larger Chemist Warehouse, Amcal and Eucalyptus operations, down to 2,000 to 5,000 square metres for the smaller telehealth-pharmacy operators. The facility comprises: a receiving and goods-in dock with quarantine area for incoming pharmacy stock; the main pick-and-pack area with shelving, robot dispensing systems (Omnicell, BD Pyxis automated dispensing for prescription medication; BD Rowa, Talyst, NewIcon for stock dispensing; conventional shelving for over-the-counter and high-velocity stock); a Schedule 8 controlled drug secured area; a cold-chain bay at 2 to 8 degrees Celsius for vaccine and insulin fulfilment; a frozen bay at minus 20 degrees Celsius for the smaller frozen-medication range; a packing and labelling station; a dispatch and outbound courier dock; and an office and admin area.

HVAC envelope across the fulfilment centre

Temperature 15 to 25 degrees Celsius across the entire pick area to comply with Schedule 2, 3 and 4 medication storage at the ARTG-labelled range. RH 40 to 60 percent. AS 1668.2 minimum outdoor air across the operator-occupied zones. Conventional galvanised G90 ductwork to AS 4254 Class A throughout the bulk warehouse. The cold-chain bay uses Type 304 stainless steel inside the room body because the elevated humidity at 2 to 8 degrees Celsius challenges galvanised over the long term. The frozen bay uses Type 304 stainless for the same reason. The robot dispensing room has HEPA H13 filtered supply for dust control because tablet dust from broken or split tablets is a contamination concern for adjacent fulfilment items. Office and admin runs AS 1668.2 minimum 10 L/s per person.

The cold-chain bay

The cold-chain bay holds vaccine and insulin stock for online dispatch. Walk-in cold room at 2 to 8 degrees Celsius with dedicated refrigeration plant. Continuous temperature monitoring at 5-minute resolution per the National Vaccine Storage Guidelines. Insulated outbound shipping containers (typically polyurethane-foam panels with gel packs) hold the cold chain through last-mile courier delivery. Backup power for the cold-chain bay is mandatory — some larger fulfilment operations run dual refrigeration plant with N+1 redundancy and emergency generator support. WHO TRS 961 mapping at handover and annual re-mapping.

The robot dispensing room

The robot dispensing room contains the Omnicell, BD Rowa, Talyst or NewIcon automated stock dispensing equipment. The robot handles thousands of stock-keeping units (SKUs) across the prescription and over-the-counter range, picking individual packages against a fulfilment order list. HVAC: temperature 18 to 24 degrees Celsius for robot operating envelope (the electronics are within commercial-grade specification), HEPA H13 filtered supply for dust control because tablet and capsule dust from packaging handling is a contamination concern. The room is segregated from the rest of the warehouse by full-height partition with HEPA-filtered air movement out to the broader pick area. Pressure is slightly positive to the broader warehouse (typically plus 2 to 5 Pa).

Schedule 8 controlled drug area

The online fulfilment centre holds S8 stock for prescription dispatch in a secured area with electronic access control, CCTV monitoring, dual-staff verification at picking, and continuous temperature monitoring at 15 to 25 degrees Celsius. The S8 area is partitioned from the bulk pick area with a full-height wall and lockable access door. The HVAC envelope is the same temperature band as the broader warehouse but with the additional access-control overlay. Methadone dispensing through online fulfilment is highly regulated and typically operates only at fulfilment centres operating under a specific S8 dispensing-and-dispatch licence.

The schedule-based medication storage HVAC envelope

The Therapeutic Goods Administration through the Australian Register of Therapeutic Goods sets the labelling-specified storage temperature for every registered medication. The pharmacy HVAC envelope must hold these temperatures across the storage and dispensing lifecycle.

Room temperature 15 to 25 degrees Celsius

The default storage band for most Schedule 2, 3 and 4 medications. Includes most oral solid-dose forms (tablets, capsules, sustained-release), most oral liquid forms (syrups, suspensions), most topical preparations (creams, ointments, gels) and most injectables that do not require cold-chain. The pharmacy HVAC sets the room body to the middle of this band (typically 20 to 22 degrees Celsius) with continuous monitoring at the shelves. RH 40 to 60 percent prevents tablet swelling and label adhesion failure.

Cool 8 to 15 degrees Celsius

A smaller class of medications requires the "cool" band — some suppositories, some hormone preparations, some dermatological agents. Stored in a dedicated cool refrigerator or temperature-controlled cabinet within the dispensary or back-of-house. Continuous temperature monitoring.

Refrigerated 2 to 8 degrees Celsius

The cold-chain band for most vaccines, insulin, biologics, monoclonal antibodies, certain antibiotics (reconstituted clavulanic acid combinations), and many other temperature-sensitive medications. Pharmaceutical-grade refrigerator with continuous monitoring at 5-minute resolution.

Frozen below minus 18 degrees Celsius

A small range of frozen medications including some pre-mRNA-era frozen vaccines, some haemophilia products, certain plasma-derived therapies and some research-stage products. Pharmaceutical-grade freezer at minus 20 degrees Celsius or colder with continuous monitoring.

Ultra-low minus 80 degrees Celsius

Rare in retail but present in hospital pharmacy for COVID-19 mRNA vaccine bulk supply (the Pfizer-BioNTech and Moderna products both required minus 80 degrees Celsius during the pandemic peak and continue to require minus 80 degrees Celsius for the long-shelf-life bulk shipment configuration), certain cell-therapy products and some research medications. Ultra-low chest or upright freezer with continuous monitoring.

Ductwork material selection — the pharmacy decision matrix

The pharmacy ductwork material decision is straightforward in principle: Type 316L stainless steel for the USP <800> hazardous-drug exhaust path; Type 304L stainless for the USP <797> cleanroom envelope and the cold-chain rooms; galvanised G90 minimum for the conventional retail, warehouse and admin envelopes. The challenge is in execution — placing the stainless duct correctly across the cascade boundaries and the BSC exhaust route without over-specifying stainless where it does not add value.

Type 316L stainless — mandatory zones: (1) Class II Type B2 BSC exhaust ductwork from the cabinet discharge collar to the rooftop discharge stack; (2) Compounding Aseptic Containment Isolator (CACI) exhaust; (3) bag-in bag-out HEPA H14 housing internals and immediate downstream duct; (4) activated-carbon adsorber housing where fitted upstream of BIBO; (5) USP <800> C-SEC return paths where the room handles volatile cytotoxic vehicles; (6) any duct subject to ozone or peracetic acid exposure during a Sterrad or VHP cycle; (7) any duct subject to chloride-bearing cleaning chemistry (sodium hypochlorite is standard cytotoxic surface disinfection).

Type 304L stainless — recommended zones: (1) USP <797> ISO 7 Grade B buffer room supply, return and exhaust; (2) USP <797> ISO 8 Grade C ante-room supply, return and exhaust; (3) USP <800> ante-room supply and return; (4) non-sterile extemporaneous compounding HEPA-filtered supply where dust control drives the cleanliness specification; (5) hospital pharmacy clean controlled dispensing and cart-filling supply; (6) cold-chain bay and frozen bay room body supply where humidity at the low temperature challenges galvanised; (7) walk-in cold room body supply.

Galvanised G90 minimum — acceptable zones: (1) retail pharmacy front-of-shop and customer area; (2) retail pharmacy back-of-house dispensary; (3) hospital pharmacy office, admin and clinical pharmacist work area; (4) bulk drug store at the room ambient envelope; (5) online fulfilment centre bulk pick area outside the robot dispensing room; (6) corridors and support zones; (7) all conventional commercial HVAC including the host building envelope where the pharmacy fit-out sits inside.

Coil traceability and audit. Stainless duct sections installed in any USP <797> or USP <800> compounding suite are mill-certified with the heat number traceable to the finished duct section. The Pharmacy Board of Australia (AHPRA) audit, the TGA inspection where the facility operates under licence, and the PIC/S PE 010 review where applicable all expect material provenance to be auditable. SBKJ supplies the SBAL-V configured with coil release tracking that captures the heat number at line entry and ties it to the production batch, satisfying the audit requirement without site-fabrication reconciliation.

HEPA filtration strategy across the pharmacy envelope

HEPA filtration is the load-bearing engineering control in every USP <797> and USP <800> compounding suite. The Class II Type A2 or Type B2 BSC supplies HEPA H14 (99.995 percent at MPPS) inside the cabinet. The ISO 7 Grade B buffer room supplies HEPA H14 terminal in the room ceiling. The ISO 8 Grade C ante-room supplies HEPA H13 (99.95 percent at MPPS) or H14. The non-sterile compounding room supplies HEPA H13 for dust control. The robot dispensing room at the fulfilment centre supplies HEPA H13. The retail and warehouse balance runs conventional MERV-rated filtration without HEPA. The validation regime is set by IEST-RP-CC034 (in-place HEPA filter integrity testing) and ISO 29463 (HEPA filter classification).

Plenum design and gel seal

Every HEPA filter sits in a plenum box with a gel seal frame — a viscous silicone or polyurethane compound in a channel around the filter perimeter into which the filter's knife-edge gasket seats. The gel seal accommodates minor dimensional variation, holds across thermal cycling and decontamination exposure, and is straightforward to validate at change-out. The plenum has an upstream test port for PAO challenge injection and a downstream port for photometer scanning. Plenum fabrication is the demanding test of duct manufacturing capability. A 2 mm out-of-square on the filter seat compromises the gel seal and the filter leaks past the frame. SBKJ supplies the SBAL-V configured to produce plenum sections to dimensional tolerance and the SB-ZF1500 stitchwelder for the welded plenums required by the BSC exhaust path, ISO 5 LAF plenum and the bag-in bag-out housing.

The bag-in bag-out housing in detail

The bag-in bag-out (BIBO) HEPA housing for USP <800> cytotoxic exhaust is a fabrication-intensive item. The housing is a Type 316L stainless steel cabinet, fully welded internals to SMACNA Seal Class A, sized to accept standard 610 by 610 millimetre H14 filter modules (or larger 610 by 1,220 millimetre modules at higher airflow). The bag-in bag-out port is on the side of the housing with a sleeve that accepts the change-out plastic bag. Bubble-tight isolation dampers (Class 4 leakage to AMCA 511) upstream and downstream isolate the filter chamber during change-out. The housing is decontaminated with VHP or formaldehyde fumigation before change-out where the agent risk profile requires. Annual integrity test per IEST-RP-CC034 with PAO upstream and photometer downstream.

The SB-ZF1500 stitchwelder and HEPA housing fabrication

The SBKJ SB-ZF1500 stitchwelder is the critical machine for fabricating the BIBO HEPA housing, the ISO 5 LAF plenum, the Class II Type B2 BSC exhaust plenum and the acoustic sound attenuator sections that complete the USP <800> HVAC scope. The SB-ZF1500 produces continuously TIG-welded stainless seams to pressure-vessel-grade integrity, accepts both Type 304L and Type 316L stainless coil, and delivers the leak-tight construction that the BIBO housing demands at the AS 4254 Class C pressure class. Combined with the SBAL-V for the long straight duct runs and the SBSF-1525 stitchwelder for the smaller round and welded sections, the SB-ZF1500 closes the fabrication gap that conventional HVAC ductwork lines cannot serve.

Construction class, joint integrity and seal classes

Pharmacy compounding ductwork follows the same construction class framework as broader pharmaceutical GMP work but with a narrower set of pressure classes because the application is more localised.

AS 4254 pressure class

Most pharmacy compounding cleanroom supply ductwork falls into AS 4254 Class B (medium pressure, up to 750 Pa). The Class II Type B2 BSC exhaust falls into AS 4254 Class C (high pressure, up to 1,500 Pa) because the exhaust runs against the high static of the BIBO HEPA, the activated-carbon adsorber and the rooftop discharge stack. Retail and warehouse work is Class A (low pressure, up to 500 Pa). Sheet thickness, joint design, stiffener spacing and support spacing are calibrated to the class per AS 4254 Part 2.

Leakage class

SMACNA Leakage Class 6 or better (3 cfm per 100 sq ft at 1 inch wg, equivalent to 1.5 L/s per square metre at 250 Pa) is the USP <797> and USP <800> expectation for general pressurised cleanroom ductwork. Class 9 or better (functionally airtight) is the expectation for the Class II Type B2 BSC exhaust path. The test pressure is 1.5 times maximum operating pressure. Each duct section is tested before insulation; failure triggers re-fabrication or sealing rework.

SMACNA Seal Class A equivalent

All pharmacy compounding cleanroom ductwork is sealed to SMACNA Seal Class A equivalent — every transverse joint, every longitudinal seam, every duct wall penetration sealed. Sealants are UL 181 listed, low-VOC and compatible with the decontamination chemistry where the suite uses VHP, sodium hypochlorite or peracetic acid. For Type 316L stainless steel duct, continuously TIG-welded longitudinal seams replace mechanical sealing on the seam, with gasketed and sealed TDF flanges at every transverse joint. The result is a fully welded, leak-tight, Class A SMACNA seal class duct system throughout the USP <800> envelope.

Fire and smoke compartmentation

A pharmacy fit-out sits within the host building's fire compartmentation hierarchy. A retail community pharmacy sits inside a shopping centre, strip mall or stand-alone retail building. A hospital pharmacy sits within the hospital fire compartmentation, often as its own fire compartment to isolate the pharmacy from surrounding clinical and support areas. A specialist compounding pharmacy sits in either a stand-alone building or a commercial unit within a broader industrial estate. An online fulfilment centre is typically a stand-alone warehouse with its own fire engineering report. Fire and smoke dampers are required at every smoke partition crossing and at every floor crossing under AS 1668.1 and AS 1530.4. AS 1851 governs the maintenance regime.

For Type 316L stainless steel duct sections on the Class II Type B2 BSC exhaust, the damper sleeve installation must not compromise the welded-seam integrity. The standard practice is to install the damper sleeve as a separate fabricated unit, joined to the duct sections with gasketed TDF flanges, and the damper assembly tested as a system rather than the duct being cut into post-installation. For USP <800> hazardous-drug exhaust ductwork, fire damper integration requires careful coordination because the duct must maintain containment integrity through any credible fire event — the damper's containment function and its fire function must be satisfied simultaneously.

BMS integration and audit-trail logging

The pharmacy compounding suite operates a BMS that monitors every cascade boundary, every classified zone temperature and humidity, every HEPA filter differential pressure, every cold-chain refrigerator and frozen freezer, and the discharge fan status on the Class II Type B2 BSC exhaust. The BMS is a GxP-validated system where the facility operates under TGA licence or PIC/S PE 010 framework; otherwise the BMS is validated to a documented internal standard consistent with the Pharmacy Board of Australia audit expectation.

Pressure transducers at every cascade boundary: corridor-to-ante-room, ante-room-to-buffer room, ante-room-to-C-SEC for USP <800>. Logging at 1-minute resolution minimum. Warning at 50 percent of design differential, critical alarm at 25 percent or inversion. Door-side green and red LED indicators.

Temperature and humidity loggers at every classified zone, every cold-chain refrigerator, every frozen freezer and the ultra-low freezer where present. Resolution 5-minute minimum (1-minute for the buffer room and cold chain). Data retained for the life of the compounded preparation plus 5 years minimum.

HEPA differential pressure across every filter bank, with change-out alarm at twice the clean-state value. Data used to predict change-out intervals and to optimise the maintenance schedule.

BSC discharge fan status on the Class II Type B2 BSC exhaust: fan run/stop, fault, differential pressure across BIBO HEPA, exhaust velocity at the discharge stack. Loss of discharge for more than 60 seconds is a USP <800> non-conformance event logged for review.

Cold-chain monitoring on every pharmaceutical refrigerator, freezer and walk-in cold room. Temperature at 5-minute resolution per the National Vaccine Storage Guidelines. Backup power for monitoring is mandatory — loss of monitoring for more than 60 minutes invalidates the stored stock.

Audit trail and data integrity. Audit-trail capability on every change to a monitored parameter. Access control with named users, no shared accounts. Backup and disaster recovery to a documented Recovery Time Objective. Annual periodic review of audit-trail data is the QCPP and SHPA expectation.

Construction sequencing and the SBKJ machine pattern

A new-build pharmacy compounding HVAC scope typically runs 4 to 12 months from possession through commissioning. The sequence is broadly: month 1 demolition (in retrofit), base-build alterations and structural penetrations for the rooftop discharge stack; months 2 to 4 fabrication and delivery of the Class II Type B2 BSC exhaust ductwork, BIBO HEPA housing, ISO 5 LAF plenums and ISO 7 buffer room terminal plenums; months 3 to 6 ceiling-void rough-in for supply, return, exhaust, BMS and process services; months 5 to 8 partition installation, ceiling closure, HEPA plenum mounting and BSC installation; months 7 to 10 SMACNA leakage testing, pressure verification and ISO 14644 validation; months 9 to 12 final commissioning, BMS validation, BSC NSF/ANSI 49 commissioning, environmental monitoring baseline and Pharmacy Board of Australia notification or TGA licence amendment as applicable.

The SBKJ machine recommendation

The SBAL-V auto duct line is the SBKJ flagship for the high-output, stainless-capable fabrication required by pharmacy compounding HVAC scopes. Specifications: 16 metres per minute working speed, 87 kilowatt installed power, 0.5 to 1.5 millimetre coil thickness, 1,500 millimetre maximum coil width. The line is configured for Type 304L stainless coil for the ISO 7 Grade B buffer room and ISO 8 Grade C ante-room supply and return, switching to Type 316L stainless coil for the Class II Type B2 BSC exhaust path on USP <800> hazardous-drug compounding, with mill-certified traceability — the coil release record captures the heat number at line entry and ties it to the production batch, satisfying TGA GMP, PIC/S PE 010 and AHPRA audit expectations. The TDF flanging operation accepts gasketed sealing for HEPA-grade integrity. The line handles galvanised, Type 304 and Type 316L coil through the same forming train with a documented changeover sequence, so a single shift can fabricate multiple material specifications for the same pharmacy project — the retail front-of-shop in galvanised, the cleanroom envelope in 304L, the BSC exhaust in 316L. Fully welded leak-tight Class A SMACNA seal class throughout the USP <797> and USP <800> envelope is non-negotiable; the SBAL-V production pattern delivers it as a routine output.

For fabricators serving pharmacy projects as part of broader healthcare and cleanroom packages, the SBAL-III (14 metres per minute, 15.7 kilowatt) is the cost-effective workhorse. The SBAL-II (18 metres per minute, 5.5 kilowatt) suits smaller specialist compounding and community-pharmacy fit-outs where throughput requirements are lighter.

The SB-ZF1500 stitchwelder is the critical machine for fabricating the BSC exhaust plenums, BIBO HEPA housings, ISO 5 LAF plenums, acoustic sound attenuator sections and double-bagged HEPA bag-in bag-out housing required by USP <800> hazardous-drug compounding. The SB-ZF1500 produces continuously TIG-welded stainless seams to pressure-vessel-grade integrity in Type 304L and Type 316L stainless — the joint integrity that the USP <800> BIBO housing demands at AS 4254 Class C.

For round duct serving cleanroom return risers, HEPA bank distribution and ventilation paths, the SBSF-1525 spiral former (2.5 kilowatt) handles the bulk of the work. The larger SBFB-1500 (7.5 kilowatt, 1.20 metres per minute) handles higher-pressure spiral where AS 4254 Class C and SMACNA Class 9 leakage requirements drive the construction class up. The SBPC1500 plasma cutter handles the bespoke transitions, offsets and HEPA plenum cutouts that no automatic line can match. The SBLR-600 and SBLR-600A longitudinal welders (7.6 metres per minute) handle the long stainless seams characteristic of BSC exhaust hood and BIBO housing fabrication. The SBSF-1525 stitchwelder handles the smaller welded round and rectangular components.

Joint integrity for HEPA-filtered and BSC-exhaust systems

Duct joints in HEPA-filtered supply and BSC exhaust systems require integrity beyond conventional ducted HVAC: gasketed and sealed TDF flanges with decontamination-chemistry-compatible EPDM or silicone gaskets, mastic or butyl sealant on every joint, fully torqued clamps. The SBKJ TDF auto-cleating and flanging operation produces joint geometry that accepts this sealing without site-fabrication rework. Internal acoustic lining is generally prohibited in pharmacy compounding cleanroom ductwork (sheds fibres that compromise HEPA loading and contaminate the filtered air stream); external acoustic wrap with foil facing and low-VOC binder is the standard. The acoustic sound attenuator on the Class II Type B2 BSC exhaust is a Type 316L stainless welded section fabricated by the SB-ZF1500 stitchwelder, with the attenuator media (typically perforated stainless wall enclosing low-VOC mineral wool with stainless mesh facing) integrated as a welded assembly rather than a site-built unit.

Commissioning, validation and operational handover

A pharmacy compounding HVAC system is not commissioned until every key parameter has been measured, recorded and signed off. The handover binder is the basis of every AHPRA audit, every QCPP review, every TGA inspection where the facility operates under licence, and every PIC/S PE 010 audit where the facility operates under that framework.

Design Qualification (DQ)

The DQ documents that the HVAC design meets the user requirements (URS) and the regulatory requirements (USP <797>, USP <800>, PIC/S PE 010, TGA GMP, AHPRA, ASHRAE Standard 170 where applicable). DQ deliverables: URS sign-off; Functional Specification (FS); Design Specification (DS); risk assessment under ICH Q9-equivalent framework. DQ is completed before fabrication.

Installation Qualification (IQ)

IQ documents that the HVAC system is installed in accordance with the design and the manufacturer's specification. IQ deliverables: as-installed drawings; equipment serial number register; material certificates for every stainless coil heat number; SMACNA leakage test reports per section; calibration certificates for every BMS sensor and transducer; piping and instrumentation diagram (P&ID) sign-off; pre-commissioning checklist sign-off. IQ is completed before start-up.

Operational Qualification (OQ)

OQ documents that the HVAC system operates within design parameters across the full operating range. OQ deliverables: air balancing report (every diffuser, grille and exhaust measured); pressure relationship verification per cascade boundary; ACH verification per zone; temperature and humidity baseline over 7 days minimum; HEPA integrity test per filter per IEST-RP-CC034; ISO 14644 particle count validation per zone; BSC commissioning per NSF/ANSI 49; BIBO HEPA housing integrity test; BMS point list verification; alarm threshold verification by simulated faults; fire and smoke damper test per damper. OQ is completed before product introduction.

Performance Qualification (PQ)

PQ documents that the HVAC system operates within design parameters under routine compounding conditions. PQ deliverables: ISO 14644 in-operation particle count per zone; environmental monitoring with settle plates, surface contact plates and active air sampling over the documented qualification period; media fill simulation for aseptic operations (typically three consecutive media fills with full sterility testing); smoke pattern testing for unidirectional flow zones (BSC face and ISO 5 LAF); recovery time testing after simulated upset; full BMS data review for the qualification period. PQ is completed before commercial compounding release.

The handover binder

The handover binder integrates the DQ/IQ/OQ/PQ outputs with: SMACNA/AS 4254 leakage test reports per duct section; pressure relationship test logs; ACH verification logs per diffuser and grille; HEPA integrity certificates per filter; ISO 14644 particle count validation per zone; temperature and humidity baseline and 7-day routine logs; BMS point list with alarm verification; BSC NSF/ANSI 49 commissioning certificate; BIBO HEPA housing integrity certificate; mill certificates per stainless heat number; cold-chain mapping report per WHO TRS 961; backup power changeover test report. The binder is the basis of the AHPRA Pharmacy Board registration audit, the QCPP review where applicable, the TGA licence application where the facility operates under licence, and every subsequent inspection through the facility lifetime.

Common pharmacy compounding HVAC mistakes — and how to avoid them

The mistakes below account for most of the rework we have seen on Australian pharmacy compounding HVAC projects. Each is cheap to fix at design stage and expensive (or impossible) to fix on a registered compounding pharmacy site.

Mistake 1 — Galvanised duct inside the USP <797> or USP <800> envelope

Galvanised steel sheds zinc oxide particulate under thermal cycling and contaminates the HEPA-filtered air stream. Galvanised is unacceptable in any ISO 7 or ISO 8 cleanroom supply, return or exhaust. The fix is Type 304L stainless steel minimum across the entire USP <797> envelope and Type 316L specifically on the USP <800> BSC exhaust path.

Mistake 2 — Wrong cabinet type for hazardous-drug compounding

Compounding cytotoxic drugs in a Class II Type A2 BSC (which recirculates 70 percent) instead of a Class II Type B2 BSC (which exhausts 100 percent single-pass) creates direct cytotoxic aerosol exposure for the compounding pharmacist and the wider pharmacy. The fix is Type B2 BSC or CACI for every USP <800> hazardous-drug compounding operation, never Type A2.

Mistake 3 — Cascade direction reversed at USP <800>

Holding the C-SEC at positive pressure (instead of negative) to the ante-room allows hazardous-drug aerosol to escape into the broader pharmacy. The fix is reverse cascade for the C-SEC at minus 5 Pa minimum to the ante-room, with the ante-room remaining positive to corridor.

Mistake 4 — Missing BIBO HEPA on the BSC exhaust

A Class II Type B2 BSC exhausting through a conventional non-BIBO HEPA filter housing creates a high-risk filter change-out event — the maintenance technician is directly exposed to the cytotoxic-contaminated filter element. The fix is a bag-in bag-out housing immediately upstream of the discharge fan, with the change-out performed through the sealed bag-in port without opening the housing to atmosphere.

Mistake 5 — No activated-carbon adsorber for volatile cytotoxic vehicles

HEPA filtration captures particulate but does not capture vapour. The volatile components in paclitaxel vehicles (ethanol, polysorbate), doxorubicin vehicles, etoposide vehicles and DMSO-based formulations pass through HEPA unchanged. The fix is an activated-carbon adsorber upstream of the BIBO HEPA, sized for the volatile inventory and the cabinet airflow, with documented replacement schedule and breakthrough monitoring.

Mistake 6 — BSC exhaust discharge too close to outdoor air intakes

Cytotoxic exhaust discharged within 8 metres of an outdoor air intake or operable window re-enters the building through the intake. The fix is discharge vertically upward, minimum 3 metres above roof, minimum 8 metres horizontal from any intake, with discharge velocity 12 m/s minimum.

Mistake 7 — Cold-chain monitoring without backup power

Loss of cold-chain monitoring for more than 60 minutes during a power outage invalidates the stored vaccine and insulin stock under the National Vaccine Storage Guidelines. The fix is backup power for every pharmaceutical refrigerator monitoring system, with the data-logger and the refrigeration plant on emergency power.

Mistake 8 — HEPA plenum dimensional out-of-square

A 2 mm out-of-square on the filter seat compromises the gel seal and the filter leaks past the frame. The fix is precision fabrication on the SBAL-V line with dimensional control on the cutting and bending operations, plus welded plenum sections fabricated by the SB-ZF1500 stitchwelder for the BSC exhaust and BIBO housing — rather than site-fabrication that depends on hand-shimming for fit.

Mistake 9 — Internal acoustic lining in compounding cleanroom ductwork

Internal acoustic lining sheds fibres that compromise HEPA loading and contaminate the filtered air stream. The fix is external acoustic wrap with foil facing and low-VOC binder, and where the BSC exhaust acoustic attenuation requires media internal to the duct, a welded stainless attenuator section with perforated stainless wall enclosing low-VOC mineral wool behind stainless mesh facing.

Mistake 10 — No fan redundancy on the BSC exhaust

A single-fan exhaust on the Class II Type B2 BSC is a single point of failure. Loss of the fan means loss of containment. The fix is N+1 fan redundancy with automatic changeover, monitored on the BMS, and emergency power that holds the exhaust running through grid loss.

Mistake 11 — Missing or unvalidated BMS

A BMS that is not validated, or no BMS at all, is an AHPRA audit non-conformance for any USP <797> or USP <800> compounding operation. The fix is full DQ/IQ/OQ/PQ validation of the BMS at commissioning, with audit trail, access control and disaster recovery documented and tested.

Mistake 12 — S8 safe in an inadequate environment

The S8 controlled drug safe placed in an environment outside 15 to 25 degrees Celsius compromises the drug stability and creates a Pharmacy Board of Australia audit non-conformance. The fix is climate-controlled placement with continuous temperature monitoring inside the safe and BMS alarming.

Mistake 13 — Methadone dispensing without acoustic privacy

The methadone dispensing window or counter that is acoustically open to the broader retail or pharmacy space creates a patient confidentiality breach contrary to the AHPRA Code of Conduct. The fix is acoustic privacy on the dispensing booth, achieved through external acoustic wrap on the partition and dedicated air supply that does not require open transfer grilles.

Mistake 14 — Cytotoxic ductwork in galvanised steel

Galvanised steel duct on the Class II Type B2 BSC exhaust path corrodes under the chloride exposure from sodium hypochlorite cleaning and the volatile chemotherapy vehicle exposure. The fix is Type 316L stainless steel mandatory from the BSC discharge collar to the rooftop stack, continuously TIG-welded with gasketed sealed TDF flanges throughout.

Mistake 15 — Vaccine refrigerator monitoring outside the Strive for 5 standard

Vaccine refrigerator monitoring at intervals coarser than 5 minutes, or with data not retained for the National Immunisation Program audit period, fails the Strive for 5 cold-chain protocol. The fix is continuous data-logger at 5-minute resolution, BMS-integrated or stand-alone, with data retention per the National Immunisation Handbook protocol and the State health department vaccine storage policy.

Energy, sustainability and operating cost

A pharmacy compounding HVAC system runs continuously to hold the cleanroom envelope, the pressure cascade and the cold-chain storage. The energy cost is substantial for a sterile compounding suite (less so for a conventional retail pharmacy). For a major hospital pharmacy with TPN compounding and cytotoxic chemotherapy compounding, HVAC energy is typically 0.5 to 2 gigawatt-hours per year — smaller than a pharmaceutical manufacturing facility but still material. Design choices that affect operating cost: variable-speed fans on every supply and exhaust with BMS modulation to maintain pressure cascade and ACH; occupancy-modulated ACH (reducing the buffer room from 50 ACH to a maintenance ACH of 10 to 20 overnight while preserving the cascade); heat recovery on outdoor air paths through runaround glycol coils or plate heat exchangers (not thermal wheels because cross-contamination risk is unacceptable in a compounding context); high-efficiency reverse-cycle heat pumps for the broader pharmacy envelope.

NCC Section J sets minimum energy efficiency expectations for new and refurbished pharmacy fit-outs. Compliance typically requires variable-speed AHU fans, efficient chillers, heat recovery on outdoor air paths and demand-control where appropriate. A NABERS rating on the host building further constrains the pharmacy tenancy's HVAC choices in many large-shopping-centre and CBD locations.

Refurbishment versus new fit-out

A growing share of Australian pharmacy compounding HVAC work is refurbishment of existing hospital pharmacy and specialist compounding facilities to USP <797> 2023 revision and USP <800> standards. The refurbishment challenge is fitting modern Class II Type B2 BSC exhaust, BIBO HEPA housing, reverse-cascade C-SEC and full BMS integration into ceiling voids and AHU plant designed for an earlier specification. Three common refurbishment patterns: (1) phased zone-by-zone refurbishment with one suite at a time taken offline; (2) decant to temporary compounding capacity (contracting Slade Pharmacy or National Custom Compounding for the duration of the refurbishment); (3) greenfield replacement on the same campus or at a nearby site, with the legacy compounding suite decommissioned after the new build is qualified.

Procurement and commercial pattern

Pharmacy HVAC procurement runs through several channels in Australia. The retail pharmacy chain channel is procured through corporate construction and fit-out teams at Chemist Warehouse (Sigma Pharmaceuticals supply chain), Priceline (Wesfarmers), Sigma Healthcare's Amcal and Guardian operations, TerryWhite Chemmart, Pulse Pharmacy and Direct Chemist Outlet. Procurement typically runs through a centralised process with state-specific execution; new-store fit-outs are tendered to retail fit-out builders who in turn subcontract the mechanical scope. The hospital pharmacy channel — NSW Health, Victorian Department of Health, Queensland Health, SA Health, WA Health, ACT Health, Tasmanian Health, NT Health, Ramsay Health Care, Healthscope, Calvary, Mater, St John of God, Cabrini, Epworth — procures through hospital capital works teams supported by specialist healthcare consulting engineers and HVAC contractors with hospital-pharmacy experience. The specialist compounder channel — National Custom Compounding, Slade Pharmacy, Brisbane Custom Compounding, Custom Compounding Pharmacy, Optimum Pharmacy Plus, Wholistic Healthcare, IDT Australia and Catalent Australia — procures through internal capital works programmes that run smaller scopes more frequently than the hospital channel. The online fulfilment channel — Chemist Warehouse online, Pharmacy Online, Amcal Online, Instant Scripts, Hub Health, Eucalyptus — procures through warehouse fit-out builders with retail and pharmacy fit-out experience.

SBKJ's role across all channels is upstream of the project. We supply auto duct production lines — the SBAL-V flagship in 304L and 316L specification, the SBAL-III workhorse, the SBAL-II compact, the SB-ZF1500 stitchwelder for welded plenum and BIBO housing work, the SBSF-1525 spiral former, the SBFB-1500 higher-pressure spiral, the SBPC1500 plasma cutter and the SBLR-600 longitudinal welder — to the mechanical contractors and fabricators producing the ductwork for pharmacy and compounding scopes nationally. The standard pharmacy compounding configuration is the SBAL-V running Type 304L stainless coil for the USP <797> envelope, switching to Type 316L for the USP <800> BSC exhaust, switching to galvanised for the retail front-of-shop and warehouse balance, all within a single shift with a documented changeover sequence. The SB-ZF1500 stitchwelder runs in parallel for the BIBO housing, ISO 5 LAF plenum and acoustic sound attenuator fabrication. SBKJ engineers in our Box Hill North Victoria office provide design and fabrication support throughout the project lifecycle with a 12-hour reply commitment to spec questions — from a senior engineer, not a salesperson.

Conclusion — the engineering quality that protects pharmacists and patients

An Australian pharmacy compounding suite is a 15-to-25-year decision. The HVAC ductwork installed today will still be supporting USP <797> sterile compounding, holding the USP <800> reverse cascade, containing cytotoxic chemotherapy aerosol through bag-in bag-out HEPA H14 housing, and protecting the compounding pharmacist and patient when the current operations team has long retired. Designing it against USP <797>, USP <800>, PIC/S PE 010, TGA GMP and AHPRA expectations — Type 304L stainless across the USP <797> envelope, Type 316L on the USP <800> BSC exhaust, HEPA H14 terminal at ISO 5 PEC and ISO 7 buffer room, continuous BMS monitoring of pressure cascade and cold chain, BIBO HEPA housing on every cytotoxic exhaust path, activated-carbon adsorber for volatile vehicles, N+1 fan redundancy on the discharge stack, fully welded leak-tight Class A SMACNA seal class throughout the compounding envelope, robust DQ/IQ/OQ/PQ commissioning — costs more than a generic ducted HVAC scope. It pays for itself many times over the facility lifetime in reduced contamination risk, sustained compliance through every AHPRA and QCPP audit, lower lifecycle replacement cost (because the corrosion-vulnerable materials are placed correctly at first install), the ability to support hospital chemotherapy programs and TPN compounding without service interruption, and continuous medication availability to patients across Australia.

The Australian pharmacy and compounding sector spans 5,800 community pharmacies dominated by Chemist Warehouse, Priceline, Sigma's Amcal and Guardian brands, TerryWhite Chemmart and the independent network; every public hospital pharmacy from Royal Prince Alfred Sydney to the smallest regional health service; the private network at Ramsay Health Care, Healthscope, Calvary, Mater, St John of God, Cabrini and Epworth; the specialist compounding sector led by National Custom Compounding Brisbane and Slade Pharmacy Melbourne; and the rapidly-scaling online pharmacy sector at Chemist Warehouse online, Pharmacy Online, Amcal Online, Instant Scripts, Hub Health and the Eucalyptus brands. SBKJ supplies the auto duct production lines that fabricate the ductwork for these facilities — with the SBAL-V as the flagship configured for Type 304L and Type 316L stainless work, the SB-ZF1500 stitchwelder for welded BIBO housing and ISO 5 LAF plenum, the SBAL-III as the workhorse, the SBSF-1525 stitchwelder for HEPA filter housings and isolator make-up plenums, the SBFB-1500 spiral former for higher-pressure spiral return risers, and the broader SBKJ machine pattern (Bending Machine, Stitchwelder, Gorelocker, TDF flanging, spiral forming, plasma cutting) for the bespoke and welded fabrication. Our engineering team in Box Hill North Victoria is available to support fit-out contractors, mechanical consultants and pharmacy capital works teams throughout the design and fabrication cycle.

Whether your project is a new-build retail community pharmacy fit-out under QCPP; a hospital pharmacy refurbishment incorporating TPN compounding and chemotherapy compounding; a USP <797> sterile compounding suite at a specialist compounder; a USP <800> hazardous-drug compounding suite with Class II Type B2 BSC and BIBO HEPA exhaust; an online pharmacy fulfilment centre with robot dispensing and cold-chain bays; a Schedule 8 controlled drug safe installation; or a cold-chain vaccine storage upgrade — the engineering principles are the same, USP <797> and USP <800> are non-negotiable for compounding work, AHPRA registration standards are the regulatory floor for every pharmacy, and the design pattern set out in this guide is the SBKJ engineering team's recommended starting point.

Get an SBKJ engineering review of your pharmacy compounding HVAC specification →

FAQ

What HVAC pressure cascade is required for a hospital sterile compounding suite under USP <797>?

The Primary Engineering Control (an ISO 5 Class II Type A2 BSC or LAFW) sits inside an ISO 7 Grade B buffer room held at +5 Pa minimum to an ISO 8 Grade C ante-room. The ante-room is held at +5 Pa to the unclassified corridor. Total pressure gradient corridor to buffer room is +10 Pa minimum. Buffer room 30 to 60 ACH HEPA H14 terminal supply; ante-room 20 to 30 ACH HEPA H13 or H14. Continuous BMS monitoring of every cascade boundary, alarm at 50 percent of design differential, audit-trail logging per TGA GMP and PIC/S PE 010 expectations.

How does the cascade differ for USP <800> cytotoxic and chemotherapy hazardous-drug compounding?

USP <800> reverses the cascade inside the compounding suite. The hazardous-drug buffer room (C-SEC) is held at -5 Pa minimum to the ante-room. The ante-room remains +5 Pa to corridor. Net airflow: corridor positive, ante-room positive to corridor, C-SEC negative to ante-room — containing the cytotoxic aerosol while preventing corridor air entering. The PEC is a Class II Type B2 BSC (100 percent exhaust to outdoor through HEPA H14 single-pass with no recirculation) or a Compounding Aseptic Containment Isolator (CACI).

What is a Class II Type B2 BSC and why is it mandatory for cytotoxic compounding?

A Class II Type B2 BSC is a totally exhausted BSC — 100 percent of cabinet airflow is exhausted to outdoor through HEPA H14 single-pass via a dedicated exhaust stack with no recirculation. The Type B2 configuration ensures that any cytotoxic, chemotherapy or hazardous-drug aerosol generated inside the cabinet during reconstitution leaves the building entirely. USP <800> mandates Type B2 BSC or CACI for handling antineoplastic hazardous drugs including 5-fluorouracil, doxorubicin, cyclophosphamide, cisplatin, paclitaxel, vincristine, methotrexate, tamoxifen, irinotecan and etoposide. Exhaust ductwork is Type 316L stainless steel continuously TIG-welded with BIBO HEPA housing and activated-carbon adsorber.

What ductwork material is required for cytotoxic and chemotherapy hazardous-drug exhaust?

Type 316L stainless steel ductwork is mandatory for all USP <800> hazardous-drug exhaust — the Class II Type B2 BSC exhaust, CACI exhaust, BIBO HEPA housing internals and any duct downstream of the BSC up to the rooftop discharge stack. Type 316L is required for resistance to chloride pitting from sodium hypochlorite surface decontamination and to peracetic acid where used, plus resistance to the volatile cytotoxic vehicles (ethanol, DMSO, propylene glycol, polysorbate). Supply ductwork inside the ante-room and buffer room is Type 304L stainless minimum. Galvanised is unacceptable anywhere inside the USP <800> envelope.

What HVAC scope serves a retail community pharmacy in Australia?

Retail community pharmacy (Chemist Warehouse, Priceline, Sigma Amcal and Guardian brands, TerryWhite Chemmart, Pulse Pharmacy, Direct Chemist Outlet, Soul Pattinson) operates under conventional commercial retail HVAC with AS 1668.2 minimum 10 L/s per person outdoor air. The dispensing counter and back-of-house dispensary use the same envelope with tighter temperature control at 15 to 25 degrees Celsius for Schedule 2/3/4 medication storage. Schedule 8 controlled drug storage is in a secure climate-controlled CD safe with continuous monitoring. Cold-chain vaccine and insulin at 2 to 8 degrees Celsius uses pharmaceutical-grade refrigerators with 5-minute data-logger recording per the National Vaccine Storage Guidelines.

How is a TPN total parenteral nutrition compounding suite specified?

TPN compounding is a USP <797> Category 2 operation. The PEC is a Class II Type A2 BSC or LAFW providing ISO 5 Grade A unidirectional airflow. The PEC sits inside an ISO 7 Grade B buffer room at +5 Pa minimum to an ISO 8 Grade C ante-room. Buffer room 30 to 60 ACH HEPA H14 supply, ante-room 20 to 30 ACH. Temperature 18 to 22 degrees Celsius, RH 30 to 60 percent. Ductwork Type 304L stainless steel minimum. Operators include Slade Pharmacy Melbourne, National Custom Compounding Brisbane and the in-house TPN services at major Australian tertiary hospitals.

What HVAC serves an online pharmacy fulfilment centre with robot dispensing?

Online pharmacy fulfilment centres (Chemist Warehouse online, Pharmacy Online, Amcal Online, Instant Scripts, Hub Health, Eucalyptus) operate at warehouse scale. Temperature 15 to 25 degrees Celsius across the entire pick area for Schedule 2/3/4 medication storage. S8 controlled drug area secured at the same temperature band. Cold-chain bay at 2 to 8 degrees Celsius for vaccine and insulin fulfilment. Frozen bay at minus 20 degrees Celsius. Robot dispensing room with HEPA H13 filtered supply for dust control. Ductwork conventional galvanised G90 to AS 4254 Class A for the bulk warehouse; Type 304 stainless for the cold-chain and frozen bays.

Which SBKJ machine produces ductwork for hospital pharmacy and sterile compounding scopes?

The SBAL-V auto duct line is the SBKJ flagship for stainless-capable rectangular duct fabrication serving hospital pharmacy sterile compounding, USP <797> and USP <800> scopes — 16 m/min, 87 kW, 0.5 to 1.5 mm coil, 1,500 mm coil width, configured for Type 304L stainless on the cleanroom envelope and Type 316L on the BSC exhaust path. The SB-ZF1500 stitchwelder is the critical machine for fabricating BIBO HEPA housings, ISO 5 LAF plenums, acoustic sound attenuator sections and double-bagged HEPA bag-in bag-out housing — with full TIG seam welding for pressure-vessel-grade integrity. The SBSF-1525 spiral former, SBFB-1500 spiral former, SBPC1500 plasma cutter and SBLR-600 longitudinal welder complete the SBKJ machine pattern.

Which Australian operators run major pharmacy and compounding HVAC scopes?

Retail: Chemist Warehouse (Sigma supplied, 500+ stores), Priceline (Wesfarmers), Sigma Healthcare (ASX:SIG) supplying Amcal and Guardian, Soul Pattinson (ASX:SOL), TerryWhite Chemmart, Pulse Pharmacy, Direct Chemist Outlet, Pharmacy 4 Less. Hospital: every public hospital network (NSW Health, VIC DH, QLD Health, SA Health, WA Health, ACT, TAS, NT) and private (Ramsay Health Care ASX:RHC, Healthscope, Calvary, Mater, SJOG, Cabrini, Epworth). Compounding: National Custom Compounding Brisbane, Slade Pharmacy Melbourne, Brisbane Custom Compounding, Custom Compounding Pharmacy Sydney, Optimum Pharmacy Plus, Wholistic Healthcare, IDT Australia Boronia, Catalent Braeside. Online: Chemist Warehouse online, Pharmacy Online, Amcal Online, Instant Scripts, Hub Health, Eucalyptus (Mosh, Pilot, Compound brands).